134 related articles for article (PubMed ID: 29549921)
1. Microparticles in Hematological Malignancies: Role in Coagulopathy and Tumor Pathogenesis.
Ball S; Nugent K
Am J Med Sci; 2018 Mar; 355(3):207-214. PubMed ID: 29549921
[TBL] [Abstract][Full Text] [Related]
2. Raiders of the lost mark - endothelial cells and their role in transplantation for hematologic malignancies.
Blix ES; Husebekk A
Leuk Lymphoma; 2016 Dec; 57(12):2752-2762. PubMed ID: 27396981
[TBL] [Abstract][Full Text] [Related]
3. P-selectin glycoprotein ligand-1 positive microparticles in allogeneic stem cell transplantation of hematologic malignancies.
Trummer A; De Rop C; Stadler M; Ganser A; Buchholz S
Exp Hematol; 2011 Nov; 39(11):1047-55. PubMed ID: 21864485
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms.
Taniguchi Y; Tanaka H; Luis EJ; Sakai K; Kumode T; Sano K; Serizawa K; Rai S; Morita Y; Hanamoto H; Tsubaki K; Nishio K; Matsumura I
Int J Hematol; 2017 Nov; 106(5):691-703. PubMed ID: 28780601
[TBL] [Abstract][Full Text] [Related]
5. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
6. Platelet microparticles and cancer: An intimate cross-talk.
Goubran H; Sabry W; Kotb R; Seghatchian J; Burnouf T
Transfus Apher Sci; 2015 Oct; 53(2):168-72. PubMed ID: 26542350
[TBL] [Abstract][Full Text] [Related]
7. Microparticle analysis in disorders of hemostasis and thrombosis.
Mooberry MJ; Key NS
Cytometry A; 2016 Feb; 89(2):111-22. PubMed ID: 25704723
[TBL] [Abstract][Full Text] [Related]
8. Microparticles in cancer: A review of recent developments and the potential for clinical application.
Gong J; Jaiswal R; Dalla P; Luk F; Bebawy M
Semin Cell Dev Biol; 2015 Apr; 40():35-40. PubMed ID: 25843775
[TBL] [Abstract][Full Text] [Related]
9. [Extracellular vesicles and their role in hematological malignancies].
Rzepiel A; Kutszegi N; Cs Sági J; Kelemen A; Pálóczi K; F Semsei Á; Buzás E; Erdélyi DJ
Orv Hetil; 2016 Aug; 157(35):1379-84. PubMed ID: 27569460
[TBL] [Abstract][Full Text] [Related]
10. Microparticles, vascular function, and atherothrombosis.
Rautou PE; Vion AC; Amabile N; Chironi G; Simon A; Tedgui A; Boulanger CM
Circ Res; 2011 Aug; 109(5):593-606. PubMed ID: 21852557
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of tissue factor bearing microparticles as biomarkers in allogeneic stem-cell transplantation.
De Rop C; Stadler M; Buchholz S; Eisert R; Ganser A; Trummer A
Transplantation; 2011 Aug; 92(3):351-8. PubMed ID: 21681142
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
14. Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
Klaihmon P; Phongpao K; Kheansaard W; Noulsri E; Khuhapinant A; Fucharoen S; Morales NP; Svasti S; Pattanapanyasat K; Chaichompoo P
Ann Hematol; 2017 Feb; 96(2):189-198. PubMed ID: 27900452
[TBL] [Abstract][Full Text] [Related]
15. Microparticles as biomarkers of venous thromboembolic events.
Campello E; Spiezia L; Radu CM; Simioni P
Biomark Med; 2016 Jul; 10(7):743-55. PubMed ID: 27338783
[TBL] [Abstract][Full Text] [Related]
16. Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.
Cunningham M; Marks N; Barnado A; Wirth JR; Gilkeson G; Markiewicz M
Semin Thromb Hemost; 2014 Sep; 40(6):675-81. PubMed ID: 25173498
[TBL] [Abstract][Full Text] [Related]
17. Microparticles in health and disease.
Enjeti AK; Lincz LF; Seldon M
Semin Thromb Hemost; 2008 Oct; 34(7):683-91. PubMed ID: 19085769
[TBL] [Abstract][Full Text] [Related]
18. An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful?
Burnouf T; Chou ML; Goubran H; Cognasse F; Garraud O; Seghatchian J
Transfus Apher Sci; 2015 Oct; 53(2):137-45. PubMed ID: 26596959
[TBL] [Abstract][Full Text] [Related]
19. Cell-derived microparticles: a new challenge in neuroscience.
Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
[TBL] [Abstract][Full Text] [Related]
20. Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity.
Jesel L; Abbas M; Toti F; Cohen A; Arentz T; Morel O
Int J Cardiol; 2013 Sep; 168(2):660-9. PubMed ID: 23623666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
